Trials / Completed
CompletedNCT04679597
Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 161 (actual)
- Sponsor
- Institute of Oncology Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
In a retrospective study, the investigators will compare patients with locally advanced rectal cancer with high risk factors for failure who were treated with standard therapy or with total neoadjuvant therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capecitabine | comparison of two treatments |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2020-12-22
- Last updated
- 2024-10-17
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04679597. Inclusion in this directory is not an endorsement.